Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for CancerBusiness Wire • 07/24/24
Novartis (NVS) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/18/24
Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidanceGlobeNewsWire • 07/18/24
Immunic appoints ex Novartis and Biogen exec as new COO to lead vidofludimus calcium launchProactive Investors • 07/09/24